Investment insights from Capital Group
Timeline of previous vaccine development (years)
Sources: Capital Group, NIAID, Our World in Data. Date ranges represent the approximate time between the year the pathogenic agent was first linked to the disease and the year that its vaccine became licensed in the U.S.
Sources: Capital Group, Time, Moderna, Pfizer, U.S. Food and Drug Administration, World Health Organization.
Active cancer cell therapies in development
Source: Cancer Research Institute. Data as of May 2020. Immunotherapy is the artificial stimulation of the immune system to treat cancer. The seven categories of immunotherapy are based on the mechanism of actions to treat cancer.
Past results are not a guarantee of future results. The value of investments and income from them can go down as well as up and you may lose some or all of your initial investment. This information is not intended to provide investment, tax or other advice, or to be a solicitation to buy or sell any securities.
Statements attributed to an individual represent the opinions of that individual as of the date published and do not necessarily reflect the opinions of Capital Group or its affiliates. All information is as at the date indicated unless otherwise stated. Some information may have been obtained from third parties, and as such the reliability of that information is not guaranteed.